Document Detail


Use of everolimus-eluting stent with a bioresorbable polymer coating for treatment of recurrent in-stent restenosis.
MedLine Citation:
PMID:  15687539     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Recently, an everolimus-eluting stent utilizing a bioresorbabale PLA polymer coating to release the agent everolimus has proven safe and effective in preventing restenosis for up to six months in de novo coronary arteries. But the use of a bioresorbable polymer-coated everolimus-eluting stent for in-stent restenosis lesions has not been previously investigated. This is a case report of one-year angiographic follow-up results after the implantation of a bioresorbable PLA polymer-coated everolimus-eluting stent for the treatment of recurrent in-stent restenosis. The case involved a 63-year-old female who had repeatedly presented with recurrent in-stent restenosis in the LCX. We successfully treated this recurrent ISR lesion by using a bioresorbable PLA polymer-coated everolimus-eluting stent; the one-year follow-up angiography revealed prevention of ISR after the implantation of this device.
Authors:
Hidehiko Honda; Taiichiro Meguro; Kaname Takizawa; Shogen Isoyama
Related Documents :
17291149 - Complement component c5a predicts restenosis after superficial femoral artery balloon a...
7867179 - Coronary stenting decreases restenosis in lesions with early loss in luminal diameter 2...
11977999 - Association of plasma homocysteine with restenosis after percutaneous coronary angiopla...
11691519 - Intravascular ultrasound-guided percutaneous transluminal coronary angioplasty with pro...
21316769 - Cardiac electrical remodeling in health and disease.
18054069 - Relevance of hemostasis on restenosis in clinically stable patients undergoing elective...
19452609 - Clinical assessment and rest and stress echocardiography for prediction of long-term pr...
21097329 - Factor analysis of ventricular contraction using spect-erna images.
11356619 - Coronary and myocardial effects of acetaminophen: protection during ischemia-reperfusion.
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  The Journal of invasive cardiology     Volume:  17     ISSN:  1042-3931     ISO Abbreviation:  J Invasive Cardiol     Publication Date:  2005 Feb 
Date Detail:
Created Date:  2005-02-02     Completed Date:  2006-04-25     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8917477     Medline TA:  J Invasive Cardiol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  112-5     Citation Subset:  IM    
Affiliation:
Division of Cardiology, Heart Center, Sendai Kosei Hospital, 4-15 Hirose-machi, Aoba-ku, Sendai, Miyagi, 980-0873, Japan. h-honda@sij.co.jp
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Angioplasty, Transluminal, Percutaneous Coronary
Blood Vessel Prosthesis Implantation
Coated Materials, Biocompatible / therapeutic use*
Coronary Angiography
Coronary Artery Bypass
Coronary Restenosis / etiology*,  radiography,  therapy*
Female
Humans
Immunosuppressive Agents / therapeutic use*
Middle Aged
Myocardial Infarction / radiography,  therapy
Polymers / therapeutic use*
Reoperation
Sirolimus / analogs & derivatives*,  therapeutic use
Stents*
Chemical
Reg. No./Substance:
0/Coated Materials, Biocompatible; 0/Immunosuppressive Agents; 0/Polymers; 159351-69-6/everolimus; 53123-88-9/Sirolimus

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Reversible severe ischemic mitral regurgitation and cardiogenic shock as a complication of percutane...
Next Document:  Perspective on BRCA1.